Log in

USA: green light to the first anti-cancer drug targeting tumors with a specific genetic profile

The US Food and Drug Administration (FDA) gave its green light Tuesday to the launch of a first anti-cancer drug, Keytruda from Merck Laboratories, which targets tumors with a specific genetic profile Not the affected organ.


Election of the Head of the WHO in Geneva

194 Member States of the World Health Organization (WHO) will elect in camera on Tuesday the one who will replace in July the Chinese Margaret Chan, who remained at the head of this agency of the UN for more than ten years.


The global pharmaceutical market remained dynamic in 2016

Despite the trend to regulate drug prices, the global pharmaceutical market continued to grow strongly last year and should remain well-oriented by 2020, according to a study by QuintilesIMS published Friday.


Sanofi / Regeneron: US green light to treatment for rheumatoid arthritis

The French pharmaceutical company Sanofi and its American partner Regeneron have obtained the green light from the US drug authority (FDA) to market a treatment for rheumatoid arthritis, sarilumab, announced the two groups Monday in a statement.


Pharmacy: Thermo Fisher Scientific to buy Patheon 7,2 billion dollars

The American manufacturer of scientific equipment Thermo Fisher Scientific said Monday it has agreed to acquire the pharmaceutical outsourcing group Patheon to 7,2 billion, including debt.


a3p-100pxhaut logo


Commit to share
Transmit and progress together
Promoting innovation

The A3P Association is a major player in the pharmaceutical and biotechnology industry.
Created in 1986, it contributes to the good development of the production of medicines and clean and sterile equipment, it runs a network of professionals 21 000, manufacturers and suppliers, as part of International Congress and technical days.

It now has over 1700 members who share their technical experience, scientific and regulatory.

More info on video (Versiongb here )

  group    administrators A3P
& Project Managers

letter   newsletter A3P